As of June 30, 2025, the number of securities remaining available for future issuance under the Company's 2023 Omnibus Incentive Plan is 76,000.

For the three and six months ended June 30, 2025 and 2024, the Company recognized stock-based compensation expense as follows:


	Three Months Ended June 30,				Six Months Ended June 30,
(Amounts in 000’s)	2025		2024		2025		2024
Employee compensation:
Stock compensation expense	$	25	$	23	$	47	$	66
Total employee stock-based compensation expense	$	25	$	23	$	47	$	66

The following table summarizes the Company's restricted stock activity for the six months ended June 30, 2025:


	Number of Shares (000's)			Weighted Avg. Grant Date (per Share) Fair Value
Unvested, December 31, 2024		86		$	2.61
Granted		65		$	2.60
Vested		(33	)	$	2.74
Unvested, June 30, 2025		118		$	2.57

There were 65,000 restricted stock awards granted during the six months ended June 30, 2025, which will vest in two equal annual installments on June 20, 2026 and June 20, 2027. The unvested shares at June 30, 2025 will vest over the next 1.8 years with $278 thousand in compensation expense recognized over this period.

The following summarizes the Company's employee and non-employee stock option activity for the six months ended June 30, 2025:


	Number of Shares (000's)			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (000's)
Outstanding, December 31, 2024		48		$	2.68		8.5	$	—
Exercised		(48	)	$	2.68
Outstanding, June 30, 2025		—		$	—		—	$	—

No stock options were granted for the six months ended June 30, 2025. All vested stock options were exercised during the six months ended June 30, 2025; thus, there are no outstanding stock options as of June 30, 2025.

The following summarizes the Company's warrant activity for the six months ended June 30, 2025:


	Outstanding and Exercisable
	Number of Shares (000's)			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (in 000's)
Outstanding, December 31, 2024		15		$	51.00		0.2	$	—
Expired		(15	)	$	51.00
Outstanding, June 30, 2025		—		$	—		—	$	—

No warrants were granted during the six months ended June 30, 2025. All vested warrants expired during the six months ended June 30, 2025; thus, there are no outstanding common stock warrants as of June 30, 2025.